- Home
- BTAI vs KFFB Comparison
BTAI vs KFFB Comparison
Compare BTAI & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTAI | KFFB |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | United States |
| Employees | 37 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.6M | 36.5M |
| IPO Year | 2018 | 2004 |
Fundamental Metrics
Financial Performance| Metric | BTAI | KFFB |
|---|---|---|
| Price | $1.59 | $4.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $26.67 | N/A |
| AVG Volume (30 Days) | ★ 296.9K | 2.7K |
| Earning Date | 01-01-0001 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 109.52 |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $15,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $261.81 | N/A |
| P/E Ratio | ★ N/A | $58.94 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.17 | $1.96 |
| 52 Week High | $8.08 | $4.98 |
Technical Indicators
Market Signals| Indicator | BTAI | KFFB |
|---|---|---|
| Relative Strength Index (RSI) | 45.49 | 48.46 |
| Support Level | $1.50 | $4.45 |
| Resistance Level | $1.72 | $4.90 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 24.53 | 20.83 |
Price Performance
Historical ComparisonAbout BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company, through its subsidiaries, is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans, and types of deposits etc. The company mainly operates in Perry, Franklin, Boyle, and Garrard and surrounding counties in Kentucky, USA.